Methotrexate-associated lymphoproliferative disorder

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Methotrexate-associated lymphproliferative disorder (MTX-LPD) is a rare but critical complication developing in patients treated with methotrexate. Now that methotrexate is an anchor drug in the management of rheumatoid arthritis and become commonly used, MTX-LPD cases have increased. Many things has been unclear such as incidence, demographic characters, and risk factors. However, as the researches increased, several interesting topics has been demonstrated like associations with Epsteiin-Barr virus and with cell-mediated immunity. This report reviews newly the latest findings and future challenges on MTX-LPD.

Original languageEnglish
Pages (from-to)174-178
Number of pages5
JournalJapanese Journal of Clinical Immunology
Volume40
Issue number3
DOIs
Publication statusPublished - 2017

Keywords

  • Lymphoproliferative disorder
  • Methotrexate
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Methotrexate-associated lymphoproliferative disorder'. Together they form a unique fingerprint.

Cite this